The patents recognize the methods, apparatus, and systems developed to advance physiological monitoring and analysis with respiratory inductance plethysmography flow. Summary: Nox Medical has been granted patents by the US and European Patent Offices related to its respiratory inductance plethysmography (RIP) belts, essential in all Nox Medical diagnostic sleep tests. These belts, crucial for measuring respiratory effort accurately, are endorsed by the American Academy of Sleep Medicine. The new patents validate Nox’s methods and systems designed to enhance physiological monitoring and analysi ..read more

As Incannex advances IHL-42X, a cannabinoid combination product, into phase 2/3 clinical trials for treating OSA, CEO Joel Latham praises early trial outcomes, signaling strong potential for the drug’s marketability. Summary: Incannex Healthcare Inc provided an update on its phase 2/3 trials of IHL-42X, its drug candidate being developed for the treatment of obstructive sleep apnea (OSA), detailing preparation across 25 US sites with expansion plans into Europe. This proprietary drug, combining dronabinol and acetazolamide, aims to provide a pharmacological alternative to the commonly used PAP ..read more

The collaboration introduces a digital sleep care platform that aims to reduce workplace-related health issues and optimize employee performance through improved sleep quality. Summary: Evry Health has teamed up with Somnology Inc to incorporate sleep and behavioral health services into employee wellness programs through Somnology’s Sleep Lab as a Service platform. This partnership aims to enhance workplace health, improve performance, and reduce healthcare costs by addressing poor sleep quality, which is linked to various health issues including heart disease, diabetes, and depression. The Sl ..read more

Bridget Armstrong, PhD, will use the five-year grant to test a wearable device that monitors children’s activity and sleep, designed to be comfortable, unobtrusive, and child-friendly for long-term wear. Summary: Bridget Armstrong, PhD, has been awarded a $3.5 million grant from the NIH to test PATCH, a device designed to monitor children’s health metrics such as activity levels and sleep. Unlike existing trackers that are not tailored for children, PATCH is small, unobtrusive, and custom-made for comfort and long-term wear, utilizing open-source software to allow researchers direct access to ..read more

Axsome Therapeutics Inc will present new data on solriamfetol’s cognitive and wake-promoting effects at the American Academy of Neurology 2024 annual meeting.  Solriamfetol (brand name Sunosi, Axsome) is approved for patients with excessive daytime sleepiness due to narcolepsy and obstructive sleep apnea. Details for the presentations are as follows: Title: Solriamfetol improves cognitive performance in preclinical models of sleep apnea and in a randomized placebo-controlled study of sleep apnea participants (SHARP) P Lead author: David Gozal, MD, MBA, Marie M. and Harry L. Smith Endowed ..read more

Blake Parker, general manager at Right2Drive, outlines five major signs of driver fatigue, which contributes to an estimated 30% of major road accidents in Australia. Summary: Blake Parker, general manager at Right2Drive in Australia, emphasizes the importance of recognizing the signs of driver fatigue to enhance road safety. Key indicators include sore or heavy eyes, delayed reaction times, lane drifting, varied driving speeds, and reduced concentration. Parker notes that lack of quality sleep, often due to irregular work patterns like those of shift workers, is a primary cause of driver fati ..read more

The latest Gallup poll shows a sharp decline in sleep duration, with significant stress increases reported, especially among women under age 50. Summary: A new Gallup poll indicates that 57% of Americans feel they need more sleep, a reversal from 2013 figures when the majority felt they were getting enough sleep. Today, only a quarter report getting eight or more hours of sleep, while those getting less than five hours increased to 20%. Women, particularly under 50, report the greatest sleep deficiency. Stress levels parallel this decline, with 49% of Americans feeling stressed, rising to 53 ..read more

Sleep specialist Karin Johnson, MD, FAAN, FAASM, vice president of Save Standard Time, spreads awareness of the harmful impacts of DST. By Chaunie Brusie, RN, BSN While many people mark Daylight Saving Time (DST) on their calendars with a groan of annoyance, sleep physician Karin Johnson, MD, FAAN, FAASM, sees the twice-yearly time changes as something far more serious. According to Johnson, vice president of the nonprofit Save Standard Time and co-chair of the American Academy of Sleep Medicine’s (AASM) Coalition for Permanent Standard Time steering committee, the DST changes that occur in th ..read more

Maurits S. Boon, MD, who contributed to Nyxoah’s DREAM US trial for the Genio system, brings surgical and academic expertise in hypoglossal nerve stimulation. Summary: Nyxoah SA has appointed Maurits S. Boon, MD, who is recognized for his work in hypoglossal nerve stimulation therapy to treat obstructive sleep apnea, as chief medical officer. Boon, from Thomas Jefferson University, contributed to Nyxoah’s DREAM US trial, which demonstrated a 70.8% reduction in the apnea-hypopnea index with the Genio system. His expertise will support Nyxoah’s US Food and Drug Administration approval efforts an ..read more

Insights from expiratory positive airway pressure experts at BRYGGS Medical, AirAvant Medical, CPAPnea Medical Supply, and Open Airway Dental Solutions. By Lindsey Nolen Sleep Review facilitated a roundtable to examine expiratory positive airway pressure (EPAP) therapies that are cleared by the US Food and Drug Administration (FDA) for obstructive sleep apnea (OSA) and snoring. EPAP makers discussed expiratory resistance levels, design optimization, efficacy, technological advancements, and more. The panelists were: Geoffrey Sleeper, BS, RRT, president, BRYGGS Medical, marketer of ULTepap for ..read more